ArticleChemical research in toxicology2023
Cytocompatibility of Ti
Article in Chemical research in toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- MXenes at the Immune Interface: A Perspective on Influence of Physicochemical Design in Immunomodulation.ACS omega · 2026Review
- Review
- MXene Bioinks for 3D Bioprinting: Design and Translation.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
- Cuttlefish Ink-Derived Melanin/MXene Composites: Boosting Stability and Unleashing Synergistic Photothermal-Mechanical Antimicrobial Effects Against Biofilms.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Size Scaling of the Electrochemical Performance of TiSmall (Weinheim an der Bergstrasse, Germany) · 2026Article
- MXene/TiOInternational journal of molecular sciences · 2026Article
- Size Scaling of the Electrochemical Performance of TibioRxiv : the preprint server for biology · 2026Article
- Multifunctional Magnetic Biochar Nanocomposite for Sustainable Water Treatment, Antimicrobial, Antioxidant, and Biocompatibility Investigations.ACS omega · 2026Article
- Beyond graphene: the MXene era in bioprinting.Biomedical engineering online · 2026Review
- Mesenchymal Stem Cell-Inspired Microneedle Platform for NIR-responsive Immunomodulation and Accelerated Chronic Wound Healing.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Biocompatibility and immunomodulation of MXenes for targeted delivery of bioactive agents and drugs.Bioactive materials · 2026Review
- MXenes in diabetes: diagnostic and therapeutic applications.RSC advances · 2025Review
- MXene-based SERS spectroscopic analysis of exosomes for lung cancer differential diagnosis with deep learning.Biomedical optics express · 2025Article
- Elucidation of Potential Genotoxicity of MXenes Using a DNA Comet Assay.ACS applied bio materials · 2024Article
- MXenes and artificial intelligence: fostering advancements in synthesis techniques and breakthroughs in applications.RSC advances · 2024Review
- Targeted delivery of HSP90 inhibitors for efficient therapy of CD44-positive acute myeloid leukemia and solid tumor-colon cancer.Journal of nanobiotechnology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Two-dimensional (2D) nanomaterials have been widely used in biomedical applications because of their biocompatibility. Considering the high risk of exposure of the circulatory system to Ti
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.